IXJvsXLVETF Comparison
VS
iShares Global Healthcare ETF (IXJ) belongs to the Global Large Cap segment. State Street Health Care Select Sector SPDR ETF (XLV) is part of the US Health Care segment. IXJ's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Consumer Cyclicals. In contrast, XLV's top sector exposures are Healthcare and Consumer Non-Cyclicals. IXJ is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.08% for XLV. IXJ is up 6.01% year-to-date (YTD) with -$505M in YTD flows. XLV performs better with 9.28% YTD performance, and +$631M in YTD flows. Run a side-by-side ETF comparison of IXJ and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IXJ vs XLV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/14/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IXJ XLV | -0.13%+0.21% | +7.90%+10.17% | +6.01%+9.28% | +18.74%+24.66% | +25.39%+32.38% | +26.74%+37.47% |
| Flows | IXJ XLV | --$130M | +$233M+$646M | -$505M+$631M | -$256M+$1.63B | -$567M-$4.74B | +$23M+$2.01B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IXJ XLV | +18.65%+19.69% | +15.82%+16.19% | +14.26%+14.76% | +14.56%+15.19% |
| Max drawdown | IXJ XLV | -6.30%-5.81% | -10.83%-10.51% | -18.04%-17.05% | -18.04%-17.05% |
| Max drawdown duration | IXJ XLV | 20d26d | 122d116d | 490d444d | 490d444d |
Trading data
IXJ | XLV | |
Last sale 9/15/2026 at 1:30 PM | $102.16 | $167.66 |
| Previous close 09/14/2026 | $102.27 | $167.75 |
| Consolidated volume 09/14/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
IXJ | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/15/2026 at 1:30 PM
Live
Closed
IXJ | XLV | |
|---|---|---|
| Last price | $102.16 | $167.66 |
| 1D performance | -0.11% | -0.05% |
| AuM | $4.20 B | $43.58 B |
| E/R | 0.38% | 0.08% |
Characteristics
IXJ | XLV | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | State Street Investment Management |
| Benchmark | S&P Global 1200 Health Care (Sector) Capped Index | S&P Health Care Select Sector Index |
| N° of holdings | 110 | 59 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 13, 2001 | December 16, 1998 |
| ESG | No | No |
Advertisement
Exposure
Countries
IXJ
USA
69.7%
Switzerland
10.39%
Other
19.91%
XLV
USA
97.53%
Other
2.47%
Sectors
IXJ
Healthcare
97.09%
Other
2.91%
XLV
Healthcare
97.51%
Other
2.49%
Advertisement
Diversification
IXJ
Total weight of top 15 holdings out of 15
56.91%
XLV
Total weight of top 15 holdings out of 15
71.77%
Top 15 holdings
Data as of July 31, 2026
IXJ
Eli Lilly & Co.
10.27%
Johnson & Johnson
6.92%
AbbVie, Inc.
5.11%
UnitedHealth Group, Inc.
4.35%
Merck & Co., Inc.
4.06%
Roche Holding AG
3.89%
Novartis AG
3.64%
AstraZeneca PLC
3.35%
Thermo Fisher Scientific, Inc.
2.71%
Amgen, Inc.
2.65%
Abbott Laboratories
2.33%
Gilead Sciences, Inc.
2.06%
Novo Nordisk A/S
2.05%
Pfizer Inc.
1.80%
CVS Health Corp.
1.70%
XLV
Eli Lilly & Co.
15.48%
Johnson & Johnson
10.51%
AbbVie, Inc.
7.55%
UnitedHealth Group, Inc.
6.41%
Merck & Co., Inc.
5.48%
Thermo Fisher Scientific, Inc.
3.64%
Amgen, Inc.
3.54%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.43%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
Frequently asked questions about IXJ and XLV
How have the IXJ and XLV ETFs performed in 2026?
As of September 14, 2026, IXJ is up 6.01% year-to-date (YTD), while XLV has returned 9.28%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: IXJ or XLV?
Year-to-date, the IXJ ETF saw -$505M in flows, compared to +$631M for XLV.
Which ETF is more volatile: IXJ or XLV?
Over the past year, IXJ had a volatility of 15.82%, while XLV experienced 16.19%.
Which ETF is bigger: IXJ or XLV?
As of September 14, 2026, IXJ holds $4.20 B in assets under management (AUM), while XLV manages $43.58 B.
What sectors do the IXJ and XLV ETFs invest in?
IXJ leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.
What are the top holdings of the IXJ ETF and XLV ETF?
IXJ top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: IXJ or XLV?
IXJ holds 111 securities with 56.91% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 71.77%.
Advertisement
Latest news about IXJ & XLV
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
